Cargando…
Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma
PURPOSE: To evaluate the effectiveness and safety of a modified approach using the Ex-PRESS(®) implant combined with a scleral pocket in the management of secondary open-angle glaucoma in hereditary transthyretin amyloidosis (hATTR) at our department. METHODS: This was a retrospective analysis. The...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899011/ https://www.ncbi.nlm.nih.gov/pubmed/36748048 http://dx.doi.org/10.2147/OPTH.S394360 |
_version_ | 1784882552625954816 |
---|---|
author | Vieira, Rita Marta, Ana Ferreira, André Figueiredo, Ana Reis, Rita Falcão Sampaio, Isabel Menéres, Maria João |
author_facet | Vieira, Rita Marta, Ana Ferreira, André Figueiredo, Ana Reis, Rita Falcão Sampaio, Isabel Menéres, Maria João |
author_sort | Vieira, Rita |
collection | PubMed |
description | PURPOSE: To evaluate the effectiveness and safety of a modified approach using the Ex-PRESS(®) implant combined with a scleral pocket in the management of secondary open-angle glaucoma in hereditary transthyretin amyloidosis (hATTR) at our department. METHODS: This was a retrospective analysis. The primary endpoints included Intraocular pressure (IOP) evaluation (baseline, 1st day, 1st week, 1, 3, 6, 12 months and at last follow-up) and number of hypotensive drugs (baseline, 6th, 12th months and at last follow-up). As secondary endpoints surgical complications, the need for additional glaucoma surgery and LogMAR BCVA were evaluated. Qualified and complete success were defined as ≥ 30% IOP decrease from baseline, with or without additional medications, respectively. The minimum follow-up was 12 months. RESULTS: A total of 32 eyes were included with a mean follow-up of 2.4±2.9 years. IOP decreased significantly from baseline (27.4±4.4 mmHg) to 1st day (5.00±2.9 mmHg), 1st week (6.9±4.1 mmHg), 1st month (11.7±7.8 mmHg), 3rd month (11.6±6.1 mmHg), 6th month (13.1±6.8 mmHg), 12th month (12.0±3.5 mmHg) and last visit (11.8±2.4 mmHg), p<0.001. There was also a significant reduction in the number of antiglaucoma medications from baseline (3.8±0.6) and last follow-up (0.4±0.8), p<0.001. LogMAR BCVA remained stable (0.25±0.26 at baseline and 0.25±0.24 at last follow-up), p=0.767. Transient hypotony occurred in 17 eyes (53.1%), but only 11 (34.4%) exhibited anterior chamber shallowing and needed additional care, namely cycloplegic drops and viscoelastic injection. Complete surgical success was achieved in 22 eyes (68.8%) and qualified success in 6 eyes (18.8%). Four eyes (12.5%) needed additional glaucoma surgery. CONCLUSION: The modified ExPRESS(®) technique appears to be effective, especially when low levels of IOP are required. Additionally, fewer anti-glaucoma drugs were necessary. In the other hand, hypotony was a common side effect with this procedure, although all patients were properly handled, preserving the surgical outcomes. |
format | Online Article Text |
id | pubmed-9899011 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-98990112023-02-05 Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma Vieira, Rita Marta, Ana Ferreira, André Figueiredo, Ana Reis, Rita Falcão Sampaio, Isabel Menéres, Maria João Clin Ophthalmol Original Research PURPOSE: To evaluate the effectiveness and safety of a modified approach using the Ex-PRESS(®) implant combined with a scleral pocket in the management of secondary open-angle glaucoma in hereditary transthyretin amyloidosis (hATTR) at our department. METHODS: This was a retrospective analysis. The primary endpoints included Intraocular pressure (IOP) evaluation (baseline, 1st day, 1st week, 1, 3, 6, 12 months and at last follow-up) and number of hypotensive drugs (baseline, 6th, 12th months and at last follow-up). As secondary endpoints surgical complications, the need for additional glaucoma surgery and LogMAR BCVA were evaluated. Qualified and complete success were defined as ≥ 30% IOP decrease from baseline, with or without additional medications, respectively. The minimum follow-up was 12 months. RESULTS: A total of 32 eyes were included with a mean follow-up of 2.4±2.9 years. IOP decreased significantly from baseline (27.4±4.4 mmHg) to 1st day (5.00±2.9 mmHg), 1st week (6.9±4.1 mmHg), 1st month (11.7±7.8 mmHg), 3rd month (11.6±6.1 mmHg), 6th month (13.1±6.8 mmHg), 12th month (12.0±3.5 mmHg) and last visit (11.8±2.4 mmHg), p<0.001. There was also a significant reduction in the number of antiglaucoma medications from baseline (3.8±0.6) and last follow-up (0.4±0.8), p<0.001. LogMAR BCVA remained stable (0.25±0.26 at baseline and 0.25±0.24 at last follow-up), p=0.767. Transient hypotony occurred in 17 eyes (53.1%), but only 11 (34.4%) exhibited anterior chamber shallowing and needed additional care, namely cycloplegic drops and viscoelastic injection. Complete surgical success was achieved in 22 eyes (68.8%) and qualified success in 6 eyes (18.8%). Four eyes (12.5%) needed additional glaucoma surgery. CONCLUSION: The modified ExPRESS(®) technique appears to be effective, especially when low levels of IOP are required. Additionally, fewer anti-glaucoma drugs were necessary. In the other hand, hypotony was a common side effect with this procedure, although all patients were properly handled, preserving the surgical outcomes. Dove 2023-01-31 /pmc/articles/PMC9899011/ /pubmed/36748048 http://dx.doi.org/10.2147/OPTH.S394360 Text en © 2023 Vieira et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Vieira, Rita Marta, Ana Ferreira, André Figueiredo, Ana Reis, Rita Falcão Sampaio, Isabel Menéres, Maria João Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma |
title | Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma |
title_full | Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma |
title_fullStr | Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma |
title_full_unstemmed | Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma |
title_short | Modified Technique of Ex-PRESS(®) Filtration Device Combined with a Scleral Pocket for Hereditary Transthyretin Amyloidosis (hATTR) Secondary Open-Angle Glaucoma |
title_sort | modified technique of ex-press(®) filtration device combined with a scleral pocket for hereditary transthyretin amyloidosis (hattr) secondary open-angle glaucoma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899011/ https://www.ncbi.nlm.nih.gov/pubmed/36748048 http://dx.doi.org/10.2147/OPTH.S394360 |
work_keys_str_mv | AT vieirarita modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma AT martaana modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma AT ferreiraandre modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma AT figueiredoana modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma AT reisritafalcao modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma AT sampaioisabel modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma AT meneresmariajoao modifiedtechniqueofexpressfiltrationdevicecombinedwithascleralpocketforhereditarytransthyretinamyloidosishattrsecondaryopenangleglaucoma |